Accurately sample biogenic CO₂ for confident reporting

ENVEA reveals the importance and benefits of accurately reporting biogenic CO2 emissions to the Emissions Trading Scheme (ETS) in a new free white paper.

As part of the ETS, a cap is being introduced in 2028 to limit carbon emissions, leading to financial benefits and ensuring compliance with emissions reduction frameworks.

By reducing biogenic CO2 emissions beyond the minimum compliance requirements, companies can generate carbon credits which are valuable as they can be used to trade within the ETS arena and can also be sold to others, leading to additional revenue streams.

Additionally, by reducing emissions, companies can gain from operational efficiencies that reduce costs, such as energy optimisation, and lower carbon footprints. 

Jurgen Reinmann, Regulatory Director at ENVEA, said: “Our new white paper outlines the importance as well as the benefits of accurately reporting CO2 emissions, which is not only a responsible business practice but also fast becoming the industry standard. The EU requires Waste to Energy (WtE) facilities to precisely report biogenic versus fossil CO2 emissions, with a cap on them expected to be introduced in 2028. The WtE sector must start monitoring, reporting and verifying greenhouse gas emissions in the UK from 1 January 2026.”

“Companies will have to adhere to the regulations, so we are encouraging them to get ahead of the game now. The benefits from accurately reporting emissions can be substantial, and easy to achieve with ENVEA. Our new white paper reveals the full impact of the regulations and reporting, and is available now,” he added.

ENVEA provides the industry-recognised solution for reporting biogenic CO2 emissions.

The AMESA-B sampling system accurately samples carbon emissions to help companies confidently report their biogenic CO2 emissions to meet compliance with the ETS.

The AMESA-B fulfils the requirements of EN ISO 13833. It is designed for accurate sampling and prevention of sample loss which provides accurate samples ready for analysis.

Carbon samples are analysed at an accredited laboratory using C14, the most accurate method to distinguish between fossil carbon and biogenic CO₂. Proven to deliver the most accurate reporting of biogenic CO2 emissions, the precise data capabilities provide long-term savings and work to maximise allowances. This results in payback on installation costs, with organisations recouping investment costs within a short timeframe.